Pancreatic cancer microenvironment, to target or not to target?

Ryan M Carr1, Martin E Fernandez-Zapico2

  • 1Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

EMBO Molecular Medicine
|January 10, 2016
PubMed

Insights

Researchers are seeking new cancer therapies beyond targeting cancer cells directly. Understanding the tumor microenvironment offers promising avenues for novel cancer treatment strategies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Antimicrobials have revolutionized medicine, eradicating infections.
  • The search for cancer therapies mirrors the quest for antimicrobials, aiming for targeted cell killing.
  • Cancer research increasingly focuses on molecular intricacies and genomics to find drug targets.

Purpose of the Study:

  • To explore novel therapeutic interventions for cancer.
  • To highlight the importance of the tumor microenvironment in cancer development.
  • To shift focus from solely intracellular targets to the broader tumor ecosystem.

Main Methods:

  • Review of current cancer research trends.
  • Analysis of studies investigating tumor-microenvironment interactions.
  • Integration of genomic and informatics approaches.

Main Results:

  • Traditional antimicrobial success has set a high bar for cancer therapy.
  • Genomic studies have identified intracellular drug targets.
  • Emerging research emphasizes the dynamic tumor microenvironment.

Conclusions:

  • Novel cancer therapies may arise from understanding the tumor microenvironment.
  • Targeting the interplay between tumor and its surroundings shows therapeutic promise.
  • A holistic approach considering the tumor ecosystem is crucial for future cancer treatment development.